Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018
These include: severe digestive side effects pancreatitis (inflammation in the pancreas) gallbladder problems, such as gallstones low blood sugar kidney problems boxed warning: risk of thyroid cancer severe allergic reaction suicidal thoughts or behavior Suicidal thoughts or behavior werent reported in studies of Zepbound
They dont know what theyve actually been taking, or how much. Supporters argue that allowing BPC-157 and similar peptides back on the compounding list would pave the way for safer use
It has been marketed as a recovery peptide capable of healing injured muscles, tendons and ligaments
Contact Us How Can We Help
US$ 25.07
US$ 22.34
US$ 21.62
US$ 23.15
-1775582746855.png&w=3840&q=75)
US$ 29.51
